Leptin reduces plasma ANP level via nitric oxide-dependent mechanism

Area of Science:

• Endocrinology
• Cardiovascular Physiology
• Molecular Biology

Background:

• Leptin is an adipocyte-derived hormone impacting blood pressure and metabolism.
• The atrial natriuretic peptide (ANP) system plays a crucial role in cardiovascular homeostasis.
• Understanding the interplay between leptin and the ANP system is vital for metabolic and cardiovascular research.

Purpose of the Study:

• To investigate the role of leptin in regulating the atrial natriuretic peptide (ANP) system.
• To elucidate the mechanisms by which leptin influences ANP levels and related cardiovascular parameters.

Main Methods:

• Acute intravenous infusion of rat leptin in Sprague-Dawley rats.
• Chronic hyperleptinemia induced by adenovirus-mediated gene transfer (AdCMV-leptin).
• Assessment of blood pressure, plasma ANP levels, ANP mRNA expression, and renal function.
• Pharmacological inhibition using N(omega)-nitro-l-arginine methyl ester (L-NAME) and reserpine.

Main Results:

• Leptin infusion increased blood pressure and decreased plasma ANP levels.
• The reduction in plasma ANP by leptin was prevented by L-NAME, indicating a role for nitric oxide.
• Chronic hyperleptinemia led to decreased plasma ANP and ANP mRNA, an effect abolished by L-NAME.
• Renal function and ANP receptor density remained unchanged; basal and stimulated ANP secretion from isolated atria were not affected.

Conclusions:

• Leptin indirectly inhibits ANP secretion through a nitric oxide-dependent pathway.
• This mechanism operates independently of direct effects on ANP secretion from atrial tissue.
• Leptin's influence on the ANP system may contribute to its broader effects on blood pressure and metabolism.